Human Recombinant IL3 (from E. coli)
IL-3 is a hematopoietic growth factor that promotes the survival, differentiation and proliferation of committed progenitor cells of the megakaryocyte, granulocyte-macrophage, erythroid, eosinophil, basophil and mast cell lineages. Produced by T cells, mast cells and eosinophils, IL-3 enhances thrombopoiesis, phagocytosis, and antibody-mediated cellular cytotoxicity. Its ability to activate monocytes suggests that IL-3 may have additional immunoregulatory roles. Many of the IL-3 activities depend upon co-stimulation with other cytokines. IL-3 is a species-specific, variably glycosylated cytokine. Recombinant Human IL-3 is a 15.0 kDa globular protein containing 133 amino acid residues.Manufactured using all Animal-Free reagents.
- Carrier free
- Animal-free
APMTQTTSLK TSWVNCSNMI DEIITHLKQP PLPLLDFNNL NGEDQDILME NNLRRPNLEA FNRAVKSLQN ASAIESILKN LLPCLPLATA APTRHPIHIK DGDWNEFRRK LTFYLKTLEN AQAQQTTLSL AIF
Verified by N-terminal and Mass Spectrometry analyses (when applicable).
: For research use only. Not for use in diagnostic or therapeutic procedures.
IL-3 is a hematopoietic growth factor that promotes the survival, differentiation and proliferation of committed progenitor cells of the megakaryocyte, granulocyte-macrophage, erythroid, eosinophil, basophil and mast cell lineages. Produced by T cells, mast cells and eosinophils, IL-3 enhances thrombopoiesis, phagocytosis, and antibody-mediated cellular cytotoxicity. Its ability to activate monocytes suggests that IL-3 may have additional immunoregulatory roles. Many of the IL-3 activities depend upon co-stimulation with other cytokines. IL-3 is a species-specific, variably glycosylated cytokine. Recombinant Human IL-3 is a 15.0 kDa globular protein containing 133 amino acid residues.Manufactured using all Animal-Free reagents.
- Carrier free
- Animal-free
APMTQTTSLK TSWVNCSNMI DEIITHLKQP PLPLLDFNNL NGEDQDILME NNLRRPNLEA FNRAVKSLQN ASAIESILKN LLPCLPLATA APTRHPIHIK DGDWNEFRRK LTFYLKTLEN AQAQQTTLSL AIF
Verified by N-terminal and Mass Spectrometry analyses (when applicable).
: For research use only. Not for use in diagnostic or therapeutic procedures.
- Catalog No:
- 10778-252
- 10778-254
- 10778-256
- 10778-258
- 10778-260
- 10778-262
- 10778-264
- Protein/peptide name:
- IL3
- IL3
- IL3
- IL3
- IL3
- IL3
- IL3
- Protein/peptide type:
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Species:
- Human
- Human
- Human
- Human
- Human
- Human
- Human
- Source:
- E. coli
- E. coli
- E. coli
- E. coli
- E. coli
- E. coli
- E. coli
- Animal-free:
- Y
- Y
- Y
- Y
- Y
- Y
- Y
- Endotoxin content:
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- Biological activity:
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.
- Purity:
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Formulation:
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Storage conditions:
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- Shipping temperature:
- RT
- RT
- RT
- RT
- RT
- RT
- RT
Product Family Options
- TailleOrigin
- : AF-200-03-2UG
Specifications
Cat. No.10778-252Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - : AF-200-03-10UG
Specifications
Cat. No.10778-254Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - : AF-200-03-50UG
Specifications
Cat. No.10778-256Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - : AF-200-03-100UG
Specifications
Cat. No.10778-258Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - : AF-200-03-250UG
Specifications
Cat. No.10778-260Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - : AF-200-03-500UG
Specifications
Cat. No.10778-262Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - : AF-200-03-1MG
Specifications
Cat. No.10778-264Protein/peptide nameIL3Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT



